CD103 is a marker of human suppressor cells

被引：0
作者：
Allakhverdi, Z
Fitzpatrick, D
Comeau, M
Bouguermouh, S
Sarfati, M
Delespesse, G
机构：
[1] Notre Dame Hosp, CHUM Res Ctr, Montreal, PQ, Canada
[2] Amgen Inc, Immunol Syst, Seattle, WA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.335
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
326
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [31] Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis
    Mota, Patricia Caetano
    Morais, Antonio
    Palmares, Carmo
    Beltrao, Marilia
    Melo, Natalia
    Santos, Ana Cristina
    Delgado, Luis
    [J]. RESPIRATORY MEDICINE, 2012, 106 (07) : 1014 - 1020
  • [32] Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes
    Mokrani, M'Barka
    Klibi, Jihene
    Bluteau, Dominique
    Bismuth, Georges
    Mami-Chouaib, Fathia
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (05) : 2471 - 2479
  • [33] Eribulin mesylate exerts antitumor effects via CD103
    Oya, Kazumasa
    Nakamura, Yoshiyuki
    Watanabe, Rei
    Tanaka, Ryota
    Ichimura, Yuki
    Kubota, Noriko
    Matsumura, Yutaka
    Tahara, Hideaki
    Okiyama, Naoko
    Fujimoto, Manabu
    Nomura, Toshifumi
    Fujisawa, Yasuhiro
    [J]. ONCOIMMUNOLOGY, 2023, 12 (01):
  • [34] Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
    Duhen, Thomas
    Duhen, Rebekka
    Montler, Ryan
    Moses, Jake
    Moudgil, Tarsem
    de Miranda, Noel F.
    Goodall, Cheri P.
    Blair, Tiffany C.
    Fox, Bernard A.
    McDermott, Jason E.
    Chang, Shu-Ching
    Grunkemeier, Gary
    Leidner, Rom
    Bell, Richard Bryan
    Weinberg, Andrew D.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [35] Is CD103 a good surface marker for in vivo-activated effector/memory Treg cells in patients with chronic inflammation? Unknown yet Response
    Zeng, Defu
    Zhao, Dongchang
    Nakamura, Ryotaro
    [J]. BLOOD, 2009, 113 (09) : 2120 - 2120
  • [36] CD103 fate mapping reveals that intestinal CD103tissue-resident memory T cells are the primary responders to secondary infection
    Fung, Helen Y.
    Teryek, Matthew
    Lemenze, Alexander D.
    Bergsbaken, Tessa
    [J]. SCIENCE IMMUNOLOGY, 2022, 7 (77)
  • [37] Influence of cytokines and TLR agonists on CD49a, CD49b and CD103 expression by T cells
    Melssen, Marit
    Hutchison, Clara
    Bullock, Timothy
    Slingluff, Craig
    [J]. JOURNAL OF IMMUNOLOGY, 2015, 194
  • [38] Activation of regulatory T cells by superagonistic antibodies to CD28 is determined by integrin αE (CD103)
    Hardenberg, J. B.
    Dewert, N.
    Braun, A.
    Schoen, M. P.
    [J]. EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E52 - E52
  • [39] Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
    Thomas Duhen
    Rebekka Duhen
    Ryan Montler
    Jake Moses
    Tarsem Moudgil
    Noel F. de Miranda
    Cheri P. Goodall
    Tiffany C. Blair
    Bernard A. Fox
    Jason E. McDermott
    Shu-Ching Chang
    Gary Grunkemeier
    Rom Leidner
    Richard Bryan Bell
    Andrew D. Weinberg
    [J]. Nature Communications, 9
  • [40] p38 MAPK signaling mediates retinoic acid-induced CD103 expression in human dendritic cells
    Roe, Mandi M.
    Hashimi, Marziah
    Swain, Steve
    Woo, Krista M.
    Bimczok, Diane
    [J]. IMMUNOLOGY, 2020, 161 (03) : 230 - 244
12345